Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-24

Clinical Trial Update: The Effect of Vitamin C and E Therapy on Restless Leg Syndrome in Patients With End Stage Renal Disease on Haemodialysis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the effect of vitamin C and E therapy on restless legs syndrome in patients with end-stage renal disease on haemodialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin C and E therapy

Snippet

Sponsor: King Abdulaziz University | Conditions: Restless Legs Syndrome, End Stage Renal Disease | Phase 3 | Status: UNKNOWN